{
  "chapter": "Rheumatology-Crystal Arthropathy",
  "questions": [
    {
      "q_no": 1,
      "question": "A 62-year-old man presents with sudden, severe pain in his right big toe, waking him from sleep. The joint is swollen, red, and extremely tender. He has a history of high uric acid levels and recently consumed protein-rich meals. What is the most likely diagnosis?",
      "options": {
        "A": "Pseudogout",
        "B": "Saturnine gout",
        "C": "Podagra",
        "D": "Psoriatic arthritis"
      },
      "correct_answer": "C",
      "explanation": "toe . The sudden, severe pain, swelling, and tenderness in this joint, along with the patient's history of hyperuricemia and recent high-protein meals, strongly suggest this diagnosis. Gout is the most common inflammatory arthritis, particularly in men and older women. It occurs due to chronic hyperuricemia, which leads to urate crystal deposition in joints and tissues. Clinical Features of Gout: It typically presents as an acute monoarthritis, affecting the first metatarsophalangeal (MTP) joint in over 50% of cases. Other common sites include the ankle, midfoot, knee, and small joints of the hands, wrist, and elbow, while the axial skeleton and large proximal joints are rarely involved. Tophi are firm deposits of monosodium urate crystals in soft tissues, indicating advanced, long-standing gout due to uncontrolled hyperuricemia. Key characteristics: Rapid Onset : Symptoms can escalate to maximum severity within 2–6 hours, often waking the patient in the early morning. Severe pain : Patients frequently describe the pain as the \"worst ever.\" Extreme tenderness : The affected joint is so sensitive that the patient may be unable to wear a sock or tolerate bedding on it. Marked swelling : Accompanied by red, shiny skin over the joint. Self-limiting : The acute attack typically resolves completely within 5–14 days Pseudogout (Option A): Typically involves larger joints like the knee or wrist and results from calcium pyrophosphate deposition , not urate crystals. The presentation of big toe involvement, along with a history of high uric acid, points away from pseudogout.. Saturnine gout (Option B) refers to gout associated with chronic lead exposure. Lead impairs kidney function, reducing the body's ability to excrete uric acid, resulting in hyperuricemia and the deposition of urate crystals in the joints. The absence of any lead exposure or occupational history related to lead makes this unlikely. Psoriatic arthritis (Option D) often involves multiple joints, particularly distal interphalangeal joints, and is associated with psoriasis. In this patient, there are no mentions of skin changes or other symptoms typical of psoriasis.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 2,
      "question": "A 43-year-old man presents with severe pain in his right big toe, redness, and swelling, as shown in the image. He has a history of hypertension and recently increased her consumption of red meat. Which of the following best explains the pathophysiological process leading to her condition?",
      "options": {
        "A": "Increased renal tubular secretion of uric acid",
        "B": "Decreased production of purines",
        "C": "Impaired renal excretion of uric acid",
        "D": "Increased breakdown of uric acid"
      },
      "correct_answer": "C",
      "explanation": "increased uric acid levels. Impaired renal excretion is a common cause of hyperuricemia, which can lead to the formation of monosodium urate crystals and gout attacks. Etiopathogenesis of Gout: Diminished renal excretion (Option A ruled out) : In over 90% of cases, reduced uric acid excretion due to genetic factors is the primary cause. Other causes include: Increased renal tubular reabsorption Renal failure Lead toxicity Lactic acidosis Alcohol consumption Drugs (thiazide/loop diuretics, low-dose aspirin, ciclosporin, pyrazinamide) Increased intake : Consumption of seafood, offal, and red meat, along with high fructose intake, can elevate uric acid levels. Increased production : Glycogen storage disorders (Von-Gierke) and conditions like myeloproliferative diseases, psoriasis, and certain inherited disorders (e.g., Lesch–Nyhan syndrome) can lead to excessive uric acid production. Risk factors for Gout: Metabolic syndrome High alcohol intake : Particularly beer, which contains guanosine. Osteoarthritis : Reduced levels of proteoglycans in osteoarthritic cartilage may predispose to crystal formation. Lead poisoning : Known as saturnine gout. Increased renal tubular secretion of uric acid (Option A), Decreased production of purines (Option B), Increased breakdown of uric acid (Option D): All of these will lead to lower uric acid levels and decrease gout risk formation. Hence, incorrect options.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Rheumatology-Crystal_Arthropathy_Q2_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 3,
      "question": "A 60-year-old woman with a history of elevated uric acid levels reports that she experienced a painful episode in her right big toe two months ago. Since that time, she has had no symptoms and feels completely normal. She is concerned about the possibility of future attacks. What stage of the associated condition is this patient most likely experiencing now?",
      "options": {
        "A": "Asymptomatic Hyperuricemia",
        "B": "Acute Gout Attack",
        "C": "Intercritical Gout",
        "D": "Chronic Gouty Arthritis"
      },
      "correct_answer": "C",
      "explanation": "symptom-free after her previous acute attack, indicating she is in the intercritical stage of gout , characterised by intervals between episodes of acute gout. Stages of Gout Progression: Stage 1: Asymptomatic Hyperuricemia (Option A ruled out) Elevated serum uric acid levels without any symptoms. It can last for years & individuals may be unaware of their condition. Stage 2: Acute Gout Attack (Option B ruled out) A sudden onset of severe pain, redness, and swelling in a joint , most commonly the MTP join t, typically lasts 1–2 weeks . Intense pain, extreme tenderness, and marked swelling with shiny, red skin. Symptoms usually resolve spontaneously. Stage 3: Intercritical Gout (Option C) Periods between acute attacks when the patient is symptom-free & intervals vary from weeks to years. No symptoms, but the risk of future attacks remains. Stage 4: Chronic Gouty Arthritis (Option D ruled out) Persistent joint inflammation and damage due to repeated attacks. Chronic pain and swelling, joint deformities & formation of tophi (urate crystal deposits) Tophaceous Gout: D/t deposition of urate crystals in joints and soft tissues, forming irregular, firm nodules known as tophi. These typically appear on the extensor surfaces of fingers, hands, forearms, elbows, Achilles tendons, and sometimes the helix of the ear. Tophi are usually white, which differentiates them from rheumatoid nodules. It may ulcerate, discharge white gritty material, become infected, or induce a local inflammatory response, even without secondary infection.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 4,
      "question": "A 58-year-old man presents with a sudden onset of severe pain in his left knee, accompanied by swelling and redness. He has a history of elevated uric acid levels. The physician suspects gout and plans to perform a joint aspiration for diagnostic purposes. Which of the following findings would most likely confirm the diagnosis of gout?",
      "options": {
        "A": "The presence of rhomboid-shaped crystals under polarised light",
        "B": "Elevated white blood cell count with neutrophilic predominance",
        "C": "Needle-shaped crystals exhibiting negative birefringence",
        "D": "Thickened synovial fluid with a high percentage of lymphocytes"
      },
      "correct_answer": "C",
      "explanation": "Correct answer: C) Needle-shaped crystals exhibiting negative birefringence Explanation: Gout is characterized by the identification of needle-shaped monosodium urate (MSU) crystals exhibiting negative birefringence under polarised light. Investigations Description Joint Aspiration Investigation of Choice (To confirm a presumptive diagnosis of gout) Findings: Cloudy synovial fluid; leukocyte count 5,000 to 75,000/ µ L. Thick, pasty fluid if many crystals. Crystal Analysis Type: Needle-shaped monosodium urate (MSU) crystals . Polarised light: Bright, negative birefringence (yellow parallel, blue perpendicular). Synovial Fluid Analysis Staining/Culture: Ruling out septic arthritis, as bacterial infection can coexist with MSU crystals. Serum Uric Acid Levels Acute Gout: May be falsely normal or low. Chronic Gout: Typically elevated. Additional Laboratory Tests Serum creatinine: Elevated, indicating renal involvement. Liver function tests: Assess hepatic function, particularly in older patients. Serum lipid levels: Elevated in older patients, indicating possible atherosclerosis. Radiographic features of Gout: X-ray: In advanced gout with tophaceous deposits, plain radiographs may show: Cystic changes Well-defined erosions with sclerotic margins Martel sign: Overhanging bony edges Soft tissue masses These findings are typically absent in earlier stages of the disease. Musculoskeletal ultrasound : Can aid in early diagnosis by revealing a double-contour sign over the articular cartilage, indicative of MSU deposition. Dual-Energy Computed Tomography (CT) : This technique utilises two different energy beams to identify MSU based on its chemical composition, helping to confirm the presence of MSU crystals. Rhomboid-shaped crystals (Option A) are characteristic of calcium pyrophosphate dihydrate (CPPD) crystals , which are associated with pseudogout, not gout. Elevated white blood cell count with neutrophilic predominance (Option B) can occur in gout due to inflammation, but it is not specific to gout. Neutrophilic predominance can also be seen in conditions like septic arthritis. Thickened synovial fluid with a high percentage of lymphocytes (Option D) is more indicative of conditions like rheumatoid arthritis o r other inflammatory arthritis rather than the acute inflammatory process typically seen in gout.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 5,
      "question": "A 46-year-old man presents to the OPD with severe pain, redness, and swelling in his right knee. Examination reveals tender swelling and redness at the base of the right 1st toe. Serum urate levels are normal, but arthrocentesis reveals negatively birefringent needle-shaped crystals under polarised light. Which of the following is the drug of choice for this acute attack?",
      "options": {
        "A": "Canakinumab",
        "B": "Oral colchicine",
        "C": "Intra-articular glucocorticoid injection",
        "D": "Allopurinol"
      },
      "correct_answer": "B",
      "explanation": "gout attack Colchicine (Option B) Microtubule inhibitor, which prevents microtubule assembly in neutrophils, thus reducing inflammation. Colchicine disrupts the function of the cytoskeleton by inhibiting the polymerization of beta-tubulin into microtubules. This prevents the formation and function of microtubules, which are essential for various cellular processes. By disrupting microtubule formation, colchicine inhibits the activation, degranulation, and migration of neutrophils, which are key players in the inflammatory response. This reduces the inflammatory cascade associated with conditions like gout. Colchicine does not prevent phagocytosis of uric acid crystals, but it inhibits the release of an inflammatory glycoprotein from phagocytes. This contributes to its anti-inflammatory action in conditions like gout. Colchicine blocks metaphase in dividing cells by disrupting mitotic spindle formation. DOC for acute attacks of gout. Dose: 0.6 mg TID - introduced after 2-3 days when swelling reduces. Side effects: Nausea, vomiting and diarrhoea. Avoided in elderly patients and those with renal impairment. NSAIDs It is effective when used early in an attack of gout. Indomethacin 25-50 mg TID / Naproxen 500 mg BID / Ibuprofen 800 mg TID Avoided in elderly patients and those with renal impairment Glucocorticoids (Option C) It can be used as an intramuscular injection for multi-articular involvement or intra-articular injection for mono-articular involvement, or orally. Safe to use in elderly patients and those with renal impairment. Other treatments Ice therapy: Reduces swelling and inflammation Canakinumab (IL-1 β inhibitor) (Option A) Anakinra: Reserved for resistant cases Urate lowering agents Drugs: Allopurinol, Febuoxostat, Probenecid and Pegloticase Contraindicated in acute attacks. Rapidly reduces serum urate level, which causes the dissolution of organised monosodium urate crystals. Causes an inflammatory reaction towards the shed crystals. Allopurinol (Option D) is a urate-lowering agent that inhibits xanthine oxidase, reducing urate production from hypoxanthine and xanthine. It is not recommended during active gout flares, as it can exacerbate the attack. While it lowers serum urate levels and promotes the dissolution of monosodium urate crystals, this may trigger an inflammatory reaction to the released crystals. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2864-2865 Davidson’s Principles and Practice of Medicine, 24th Edition, Page 1015 Anakinra - LiverTox - NCBI Bookshelf Colchicine - StatPearls - NCBI Bookshelf",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 6,
      "question": "A 48-year-old male presents with a 4-day history of severe pain, swelling, and redness in his right big toe. A diagnosis of acute gout was made, and treatment with NSAIDs resolved his symptoms. Investigations revealed a highly elevated serum uric acid level and increased 24-hour urinary uric acid level. Which anti-gout agent should be used in this patient?",
      "options": {
        "A": "Pegloticase",
        "B": "Allopurinol",
        "C": "Febuxostat",
        "D": "Anakinra"
      },
      "correct_answer": "B",
      "explanation": "are overproducers of uric acid. The initial dose is typically 100 mg daily, with a target urate level of <5-6 mg/dL and can be titrated up to 800 mg as needed. In patients with renal impairment, dose adjustments are essential. Adverse effects : Stevens-Johnson syndrome Toxic epidermal necrolysis Acute gout flare-up, which may occur due to rapid urate level reduction To prevent flare-ups, anti-inflammatory therapy should be continued until the patient is normouricemic and has not had an attack for 3-6 months. Management of gout Target Reduce serum urate level to < 5-6 mg / dL Acute gouty attack (Anti Inflammatory therapy) Ice pack over swelling NSAIDs (Indomethacin or Naproxen) Oral colchicine 0.6 mg TID - introduced after 2-3 days when swelling reduces Oral prednisolone 15-20 mg daily for 3 days or intramuscular methylprednisolone 80-120 mg daily for 3 days is preferred for elderly patients or polyarticular gout Anakinra - for resistant cases (Option D) Post-acute attack (based on 24-hour urinary urate level) For overproducers For under producers Allopurinol (Option B) : This is a first-line treatmen t for xanthine oxidase inhibitors. It is typically initiated at 100 mg once daily and can be titrated up to 800 mg as needed. Febuxostat (Option C) is a newer xanthine oxidase inhibitor administered at a dosage of 80-120 mg daily for patients who cannot tolerate allopurinol. Pegloticase (Option A) : Recombinant uricase enzyme used in cases resistant to standard therapy. Uricosuric agents: Probenecid Benzbromarone ( withdrawn as it is hepatotoxic) Sulfinpyrazone These agents increase the urinary excretion of uric acid, but they are contraindicated in renal impairment or urolithiasis. Patients on these drugs need to maintain high fluid intake to prevent urate crystallisation. Lifestyle measures Weight control Avoid high protein diet Avoid alcohol Avoid stress gout drugs\" data-author=\"\" data-hash=\"11266\" data-license=\"\" data-source=\"\" data-tags=\"April2025\" src=\"https://image.prepladder.com/notes/Rh1XDquw8JUhvJ2Z4KQH1745572441.png\" /> Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2864-2865 Davidson’s Principles and Practice of Medicine, 24th Edition, Page 1016",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 7,
      "question": "A 45-year-old male with stage 2 chronic kidney disease presents with painful swelling at the base of his left big toe. He was diagnosed with an acute gouty attack and treated with oral glucocorticoids. Which anti-gout medication can be used to reduce the risk of another attack without dose modification?",
      "options": {
        "A": "Probenecid",
        "B": "Allopurinol",
        "C": "Febuxostat",
        "D": "Lesinurad"
      },
      "correct_answer": "C",
      "explanation": "adjustment is required for renal impairment. Antigout agents safe to use in renal insufficiency Febuxostat Mechanism of action : Xanthine oxidase inhibitor (more effective than allopurinol) Dose: 80 to 120 mg daily Indications: Patients with the HLA-B* 5801 gene (Southeast Asians, Pacific islanders and blacks) Inadequate response to allopurinol Renal insufficiency (no dose adjustment required as it undergoes hepatic metabolism - glucuronidation and oxidation) Adverse effects of allopurinol It should be initiated during the resolution phase of an acute gout attack, and concurrent anti-inflammatory medications should be provided to prevent flare-ups. Benzbromarone Uricosuric agent (increases urinary excretion of urate) Safe to use in CKD Withdrawn due to hepatotoxicity Pegloticase Recombinant uricase enzyme, which is safe to use in CKD Used in cases resistant to standard therapy. Low dose allopurinol After dose adjustment, allopurinol may be used in patients with renal impairment. The standard dose of 100mg is reduced to 50 mg, which may be gradually increased. Probenecid (Option A) is a uricosuric second-line agent for gout . It can be used as monotherapy or in combination with allopurinol. The dose is 250 mg twice daily, which can be gradually increased to 3g / day, but it is ineffective in patients with renal insufficiency. Allopurinol (Option B) is a xanthine oxidase inhibitor and the first-line treatment for gout prevention. However, it is not safe for renal insufficiency due to its renal excretion, which increases the risk of severe cutaneous adverse reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Lesinurad (Option D) is a renal urate transporter inhibitor that targets URAT1 and OAT4 , effectively reducing uric acid reabsorption in the renal tubules. However, it is associated with elevated serum creatinine levels, making it contraindicated in patients with renal insufficiency. Reference: Harrison’s Principles of Internal Medicine, 21st Edition, Page 2864-2865 Davidson’s Principles and Practice of Medicine, 24th Edition, Page 1016 www.sciencedirect.com/science/article/abs/pii/S1471489222000686 www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/lesinurad#:~:text=Lesinurad %20was%20contraindicated%20in%20patients,of%20approved%20dosing%20%5B20%5D. pmc.ncbi.nlm.nih.gov/ articles/PMC3937145/#:~:text=Pegloticase%20treatment%20does%20not%20impact,is%20independent%20of%20 CKD%20stage.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 8,
      "question": "A 65-year-old man presents to the emergency department with sudden swelling, redness, and severe pain in both knees. He has experienced intermittent joint pain for the past few months. Polarised light microscopy of joint aspiration reveals rhomboid-shaped crystals exhibiting positive birefringence. Which statement best explains the pathogenesis of his condition?",
      "options": {
        "A": "Excessive mechanical wear and tear of the articular cartilage",
        "B": "Deposition of calcium pyrophosphate crystals in cartilage matrix vesicles",
        "C": "Excess purine production causes crystal deposition in the joints",
        "D": "Autoimmune reaction leading to pannus formation in the joint"
      },
      "correct_answer": "B",
      "explanation": "positive birefringence indicate Calcium pyrophosphate deposition disease (CPPD) or ‘Pseudogout’ in which deposition of calcium pyrophosphate crystals in cartilage matrix vesicles is seen. Calcium pyrophosphate deposition disease Aetiology Ageing Osteoarthritis Post Meniscectomy or joint trauma Familial-genetic Hemochromatosis Hypophosphatasia Hypomagnesemia Certain drugs: Thiazide and loop diuretics Malabsorption Gitelman’s syndrome Gout X-linked hypophosphatemic rickets Familial hypocalciuric hypercalcemia Pathogenesis Mutation in ANKH gene § Increased extracellular transportation of pyrophosphate. Decreased levels of glycosaminoglycans in the cartilage, which results in Increased inorganic pyrophosphate in the cartilage matrix. Calcium combines with this pyrophosphate to form excess CCP. Phagocytosis of CCP crystals by neutrophils and macrophage inflammation. Clinical features Acute attack may follow surgery (especially parathyroidectomy) and trauma Systemic signs can occur during the attack, such as fever and chills. Joint swelling,",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Rheumatology-Crystal_Arthropathy_Q8_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 9,
      "question": "A 75-year-old woman presents to the clinic with chronic pain and swelling in her shoulder joint. Radiographs reveal calcific tendinitis in the rotator cuff. A joint aspiration is performed, and the synovial fluid is analysed. If this patient has calcium apatite deposition disease, what type of crystal is most likely to be seen in the patient's synovial fluid?",
      "options": {
        "A": "Positively birefringent rhomboid-shaped crystals",
        "B": "Strong birefringent bipyramidal crystals",
        "C": "Negatively birefringent needle-shaped crystals",
        "D": "Microcrystals with no birefringence"
      },
      "correct_answer": "D",
      "explanation": "show no birefringence under polarised light. Clinical features Microscopy of synovial fluid Gout (Monosodium urate) Acute onset of severe joint pain, often at the big toe ( podagra ) Usually monoarticular . Negatively birefringent needle-shaped crystals (Option C ruled out) Pseudogout (Calcium pyrophosphate) Fever and chills Symmetrical polyarticular arthritis Maybe monoarticular Chondrocalcinosis can occur in chronic cases Positively birefringent rhomboid-shaped crystals (Option A ruled out) Calcium Apatite deposition disease It usually affects the bursae and tendons around joints. May lead to Milwaukee shoulder in the elderly. Associated with osteoarthritis Microcrystals of apatite in the synovial fluid show no birefringence under polarised light. Calcium oxalate deposition disease No specific feature Joint involvement ranges from small to large joints Variable shape and variable birefringence The most easily recognisable crystals are strong birefringent bipyramidal crystals. (Option B ruled out)",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxmedicine/Rheumatology-Crystal_Arthropathy_Q9_exp.jpg",
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    },
    {
      "q_no": 10,
      "question": "Match each condition with its corresponding key synovial fluid characteristics: Conditions Key Characteristics 1. Normal a. Yellow, Cloudy, >50,000 WBC 2. Non-inflammatory b. Colorless, Clear, <200 WBC 3. Inflammatory c. Yellow, Opaque, Positive Gram Stain 4. Septic d. Xanthochromic or Red, Bloody 5. Hemarthrosis e. Straw-like, Clear, 200 - 2000 WBC",
      "options": {
        "A": "1 - b, 2 - e, 3 - a, 4 - c, 5 - d",
        "B": "1 - a, 2 - b, 3 - e, 4 - d, 5 - c",
        "C": "1 - c, 2 - d, 3 - b, 4 - e, 5 - a",
        "D": "1 - b, 2 - c, 3 - a, 4 - d, 5 - e"
      },
      "correct_answer": "A",
      "explanation": "<200 <25% Negative Negative Non - inflammatory Straw like Clear High 200-2000 <25% Negative Negative Inflammatory Yellow Cloudy Low 2000-50000 >50% Negative Positive Septic Yellow Opaque Low >50,000 >75% Positive Negative Hemarthrosis Xanthochromic or red Bloody Variable 200-2000 50-75% Negative Negative Reference: Synovial Fluid Analysis - StatPearls - NCBI Bookshelf Arthrocentesis - StatPearls - NCBI Bookshelf",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Rheumatology-Crystal Arthropathy"
    }
  ]
}
